Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Definitive Healthcare (DH) EBITDA (2020 - 2025)

Historic EBITDA for Definitive Healthcare (DH) over the last 6 years, with Q3 2025 value amounting to -$8.7 million.

  • Definitive Healthcare's EBITDA rose 9614.5% to -$8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$297.2 million, marking a year-over-year increase of 5216.65%. This contributed to the annual value of -$710.8 million for FY2024, which is 11553.06% down from last year.
  • According to the latest figures from Q3 2025, Definitive Healthcare's EBITDA is -$8.7 million, which was up 9614.5% from -$4.2 million recorded in Q2 2025.
  • In the past 5 years, Definitive Healthcare's EBITDA registered a high of -$2.6 million during Q1 2021, and its lowest value of -$369.6 million during Q2 2024.
  • Over the past 5 years, Definitive Healthcare's median EBITDA value was -$11.9 million (recorded in 2022), while the average stood at -$68.9 million.
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 296222.35% in 2024, then skyrocketed by 9887.19% in 2025.
  • Quarter analysis of 5 years shows Definitive Healthcare's EBITDA stood at -$13.1 million in 2021, then grew by 19.55% to -$10.5 million in 2022, then increased by 4.34% to -$10.1 million in 2023, then tumbled by 887.73% to -$99.6 million in 2024, then surged by 91.27% to -$8.7 million in 2025.
  • Its EBITDA stands at -$8.7 million for Q3 2025, versus -$4.2 million for Q2 2025 and -$184.8 million for Q1 2025.